TransgenderismNCT04708600
Effectiveness of Speech Therapy in Trans Women.
A study testing Pitch Elevation Therapy and Articulation Resonance Therapy in people with Transgenderism and Gender Dysphoria, run by University Ghent at 1 site in Belgium.
Trial summary
One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more… Read more about this study
- Who is it for?
- Ages 18 to 70 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Transgenderism, Gender Dysphoria, Speech Therapy
- What is being tested?
- Pitch Elevation Therapy and Articulation Resonance Therapy
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 78 participants
- Where
- 1 siteBelgium
- Study dates
- 1 Sep 2019to 30 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- established diagnose and gender identity confirmed by the gender team,
- aged between 18 and 70 years,
- self-reported normal hearing,
- native Dutch speaker,
- under hormonal treatment (confirmed by blood analysis),
- female gender role, perceived as male speaker at the beginning of the therapy by the investigators
- speaking fo within the male or ambiguous zone (<180Hz).
Who cannot join
- history of neurological disorders, previous phonosurgery or speech therapy
- pathology of the vocal folds (observed by videolaryngostroboscopic examination of the vocal cords),
- smokers.
- to form a homogeneous study population gender non-binary persons will not be included in this study.
Trial locations and contacts
1 site in 1 country.
About this study
One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.
Read the detailed description
The main aim of this project is to investigate the short-term and long-term effect of speech therapy for pitch and resonance on vocal characteristics, listeners' perceptions and self-perception in trans women using a randomized sham-controlled trial and a longitudinal cross-over design. The goals of speech therapy are selected based on a systematic review and meta-analysis: pitch and resonance.
The first purpose is to determine and compare the short-term effect of two therapy programs Pitch Elevation Therapy (PET) and Articulation-Resonance Therapy (ART), in trans women on (a) acoustic voice characteristics investigating vocal quality, pitch and resonance, (b) listeners' perceptions using a combination of (binary) gender identification and femininity ratings using a Visual Analogue Scale (VAS) and (c) self-assessment investigating the client's satisfaction of the therapy and psychosocial functioning, using a randomized controlled trial.
Hypotheses:
- Outcome acoustic voice characteristics: Based on studies and our pilot study investigating the immediate effects of resonance and articulation exercises in trans women, a significant increase in all formant frequencies, and an increase in speaking fo is hypothesized after ART. Based on studies, an increase in speaking fo between 10 and 84Hz is hypothesized after PET. The speaking fo and formant frequencies are primary outcome measures. Vocal training and increasing pitch (during the PET) is associated with increasing vocal load and has a possible negative effect on vocal quality. Monitoring vocal quality in the three groups is therefore important. PET includes gliding tones and consequently can have a possible effect on frequency range. Therefore vocal quality and vocal range parameters are included as secondary outcome parameters. PET and ART are designed to feminize the voice without vocal misuse. Therefore, measurements of vocal quality are hypothesized to remain stable after treatment. After PET, an increase in vocal range is hypothesized.
- Outcome listeners perceptions: According to the systematic review and meta-analysis of Leung et al., pitch and resonance are the most salient listener perceptions of speaker gender. Based on the results of our pilot study, and other studies, it is hypothesized that both therapy programs, PET and ART, will result in a more feminine speech rated on a VAS. Based on the results of Gelfer et al. we hypothesize that 50% of the participants will be perceived as female after the PET therapy.
- Outcome self-assessment: Based on a retrospective study, case studies, and another study, significant improvement in psychosocial wellbeing and high levels of satisfaction with the post-treatment voice are hypothesized in both programs.
The second purpose of the study is to determine the short- and long-term effects of the whole therapy program, consisting of the combination of both PET and ART, in transwomen on (a), (b) and (c) immediately after therapy and at 3 months and 1 year using a cross-over design.
Hypotheses:
- Outcome acoustic voice characteristics: Based on a retrospective study and prospective studies on small sample sizes investigating long-term outcome of speech therapy, a small decrease of the speaking fo is hypothesized in the long-term follow-up after one year. The long-term outcome of the formant frequencies remains unclear.
- Outcome listeners perceptions: Based on a pilot study, it is hypothesized that the listeners perceptions immediately after therapy will not differ from the listeners perceptions 3 months and 1 year after therapy.
- Outcome self-assessment: Based on the results of a study and because speech is a crucial element in the psychosocial functioning of a trans women, an increasing improvement in activity and participation after 3 months and 1 year is hypothesized.
Randomized sham- controlled trial group 1 (n=26): pre sham post 1 PET post 2 ART post 3 follow-up 1 follow-up 2 group 2 (n=26): pre sham post 1 ARTpost 2 PET post 3 follow-up 1 follow-up 2
Study design. A randomized sham-controlled trial will be used to determine and compare the short-term effect of PET and ART in trans women. By adding a cross-over design, the effect of a combined treatment (PET and ART) can also be investigated, both on the short- and longer term.
Motivation: A randomized controlled trail is considered the most reliable form of scientific evidence in efficacy studies. The use of a sham therapy will take into account placebo an therapist effects. A cross-over design is used for ethical reasons, so that each subject will receive the whole voice feminization approach (PET and ART) in an acceptable time frame. Follow-up data are included to determine long-term effects of the intervention and track which subjects still need phonosurgery or further behavioral intervention.
Participants. Sample size. To date, no randomized controlled trials investigated the effect of speech therapy in transwomen. Therefore, sample size calculation was based on the study of Dacakis. This pilot study gave a minimal sample size of n = 18 participants per group (SAS, Power and Sample Size). Minimal sample size was calculated for the fundamental frequency with an α level of 0.05, a power of 80%, and a SD of 20 and 15. Taking into account a mean drop-out rate of 30%, minimal sample sizes are increased from 18 to 26 participants per group. It guarantees a large sample size to perform data-analysis with sufficient power. Taking into account the research group's expertise in the field and the accessible recruitment via the gender clinic of UZ Gent, a total of n = 78 participants is a very feasible number.
Inclusion criteria and exclusion criteria for the trans women are described further in the application.
The multidimensional voice assessment will be performed by an SLP (different from the therapist) with more than 5 years of experience of the research group who is blinded to group allocation and study evolution. Assessments will be planned before the treatment (pre), immediately after sham therapy (post 1), immediately after therapy 1 (post 2), immediately after therapy 2 (post 3) and at three months (follow-up 1) and 1 year (follow-up 2) follow-up. All measurements will be performed in a sound treated room (speech lab) at Ghent University Hospital at the department of Rehabilitation Sciences.
Listening experiment.
Listeners: An equal number of male and female naïve, native Dutch speaking laypersons (n=60), aged (and equally spread) between 20 and 49 years old, with a normal hearing will be recruited for the listening experiment. All listeners will be blinded to the purpose of the study and the gender of the speakers of the speech samples. The hearing levels of all listeners will be evaluated by the audiologists of the research team using audiometry.
Table 1: Number of listeners per age group, gender and task.
VAS-scale Binary rating M (n) F (n) M (n) F (n) 20-29y 5 5 5 5 30-39y 5 5 5 5 40-49y 5 5 5 5
Method:
The listeners, who are blinded to the purpose of the study, will be randomly assigned to 2 groups to rate audio samples on masculinity/femininity using a VAS (group 1, n=30) and gender identification (male voice versus female voice) (group 2, n=30).
Speech samples: From the speech samples of continuous speech during reading (using a phonetically balanced text) the middle sentences (+- 15 seconds) will be selected and used in the experiment. For the listening experiment E-prime 3 software is used to randomize and present the samples.
Ratings: The raters will listen once to the samples presented by E-prime 3 software during a PowerPoint presentation using a laptop and over ear headphones in a quiet sound treated room. They can include pauses to maintain concentration levels. Intensity levels will be presented at a comfortable level for the listener (approximately at 70dB at ear level). The listeners will also receive 2 other questions (distracting them from the purpose of the study) regarding the age and vocal quality of the speakers. They will rate the audio samples of all participants (n= 78) at all test moments and of 13 cis-male and 13 cis-female control persons. Inter-rater reliability will be calculated. 15% of the samples will be randomly repeated to calculate intra-rater reliability.
Speech therapy procedures. Trans women will be randomly assigned to one of the 2 groups (PET, ART) using randomization. All groups will receive the same dosage of individual therapy: 10 sessions of one hour during 5 weeks. The interventions will have an equal duration (5 sessions) and will be provided in a different order in both groups: Pitch Elevation Therapy (PET) and Articulation Therapy (ART). All therapies, including the sham therapy, will be provided by the same experienced therapist of the research group, having more than 10y of experience in this field, to control for therapist effects and assure optimal treatment fidelity. Interventions will take place in a sound treated room (speech lab) at Ghent University Hospital (dep. of Rehabilitation Sciences). PET and ART will be described in detail for the publications of this project to ensure replicability. The control group will receive information sessions regarding transgender logopaedic and general health care and, communication aspects, an active intervention for non-verbal communication skills and breathing patterns. Therefore, it is feasible to provide the same duration as the PET and ART interventions.
The same hierarchical structure will be used for both therapy programs and is based on a comprehensive literature searching.
Statistical analysis. Linear mixed model analyses (LMM) (incl. baseline analyses) will be used to determine whether there is a difference in evolution between the therapy groups over time (interaction effect time*group). Within- and between-group differences will be analyzed using post-hoc pairwise comparisons (with Bonferroni correction).
- Being tested
- Pitch Elevation Therapy, Articulation Resonance Therapy, Sham therapy
- Medical subject headings
- Transsexualism, Gender Dysphoria, Communication Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pitch Elevation TherapyBehavioural
Also called PET
Goal: mean fundamental frequency of 180Hz (range 140 and 300Hz); Doses and duration: 5 one hour sessions (5h), 5 weeks
Content:
- auditory discrimination of lower and higher tones
- pitch glides
- pitch glides using straw phonation and resonance tube phonation
- practice of higher pitch voice (target: 180Hz) in isolated vowels - syllables - mono and bisyllabic words -phrases - sentences and texts - conversation (generalization to spontaneous speech)
Articulation Resonance TherapyBehavioural
Also called ART
Goal: increase in lipspreading, forward tongue carriage, larynx elevation, forward resonance, precise articulation; 5 sessions Doses and duration: 5 one hour sessions (5h), 5 weeks
Content:
- auditory and visual discrimination of forward vs backed tongue carriage and lip spreading vs lip rounding)
- practice of technique on isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech)
- practising larynx elevation through the twang technique, isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech)
- forward resonance, focusing on oral forward resonance rather than chest resonance, isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech)
- clear, precise articulation and cork exercise
Sham therapyBehavioural
Goal: active sham treatment, 4 sessions Doses and duration: 4 one hour and 15 minutes sessions (5h), 4 weeks
Content:
- providing information about vocal function, vocal surgery, vocal hygiene, transgender health care
- discussing communication aspects and patterns, possible exercise contexts, communication partners, expectations of voice modification, conversational subjects
- active intervention on nonverbal communication (Kinesics, gestures and sign language, facial expression, haptics, proxemics, occulsics, and physical appearance)
- practising costo abdominal breathing patterns
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Experimental | Sham therapy Intervention 1: PET Intervention 2: ART Receives: Behavioral: Pitch Elevation Therapy; Behavioral: Articulation Resonance Therapy; Behavioral: Sham therapy |
| Group 2 | Experimental | Sham therapy Intervention 1: ART Intervention 2: PET Receives: Behavioral: Pitch Elevation Therapy; Behavioral: Articulation Resonance Therapy; Behavioral: Sham therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acoustics: change in speaking fundamental frequency
Median Speaking fo, fo upper limit (pc95), fo lower limit (pc25)
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Acoustics: change in formant frequencies
Median Formant Frequencies F1-F5 of the vowels /a/, /i/, /u/
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in listeners perceptions
masculinity/femininity ratings (using a VAS) and gender identification
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in self-assessment
Trans women voice questionnaire
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Secondary outcomes (3)
Change in Dysphonia Severity Index
The DSI is a multiparametric approach designed to establish an objective and quantitative correlate of the perceived vocal quality [19]. It is based on a weighted combination of 4 voice parameters: maximum phonation time (MPT, s), highest frequency (F-high, Hz), lowest intensity (I-low, dB) and jitter (%). The DSI is constructed as 0.13 MPT + 0.0053 F-high - 0.26 I-low - 1.18 jitter +12.4. The index ranges from -5 to +5 for severely dysphonic to normal voices but values higher than +5 are possible in subjects with excellent vocal capacities.
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in Acoustic Voice Quality Index
The AVQI is a robust and valid method to quantify the severity of overall dysphonia based on both continuous and sustained vowel recordings [20]. This multiparameter index consists of a weighted combination of 6 voice parameters: smoothed cepstral peak prominence (CPPS), harmonics-to-noise ratio (HNR), shimmer local (SL), shimmer local dB (SLdB), general slope of the spectrum (slope) and tilt of the regression line through the spectrum (tilt). The formula is constructed as 9.072 - 0.245 × CPPs - 0.161 × HNR - 0.470 × SL + 6.158 × SLdB - 0.071 × Slope - 0.170 × Tilt and ranges from 0 to 10. The higher the score of the AVQI, the worse is the overall vocal quality.
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in Voice Range Profile
The frequency and intensity range of the voices will be measured with the Voice Range Profile software of the Computerized Speech lab of Kay following the procedure of Heylen et al.
Measured: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2021
- Study start1 Sep 2019
- Primary completion30 Mar 2023
- Study completion30 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for TransgenderismStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 78 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Evelien D'haeseleer, PhD, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04708600
- Sponsor's protocol ID
- B670201941335
- Status last verified
- Dec 2023
- First submitted
- 14 Sep 2020
- Last updated
- 13 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Gelfer MP, Tice RM. Perceptual and acoustic outcomes of voice therapy for male-to-female transgender individuals immediately after therapy and 15 months later. J Voice. 2013 May;27(3):335-47. doi: 10.1016/j.jvoice.2012.07.009. Epub 2012 Oct 22.
PubMed 23084812Dacakis G. Long-term maintenance of fundamental frequency increases in male-to-female transsexuals. J Voice. 2000 Dec;14(4):549-56. doi: 10.1016/s0892-1997(00)80010-7.
PubMed 11130111Leung Y, Oates J, Chan SP. Voice, Articulation, and Prosody Contribute to Listener Perceptions of Speaker Gender: A Systematic Review and Meta-Analysis. J Speech Lang Hear Res. 2018 Feb 15;61(2):266-297. doi: 10.1044/2017_JSLHR-S-17-0067.
PubMed 29392290Gelfer MP, Mikos VA. The relative contributions of speaking fundamental frequency and formant frequencies to gender identification based on isolated vowels. J Voice. 2005 Dec;19(4):544-54. doi: 10.1016/j.jvoice.2004.10.006.
PubMed 16301101Carew L, Dacakis G, Oates J. The effectiveness of oral resonance therapy on the perception of femininity of voice in male-to-female transsexuals. J Voice. 2007 Sep;21(5):591-603. doi: 10.1016/j.jvoice.2006.05.005. Epub 2006 Jul 5.
PubMed 16822646Soderpalm E, Larsson A, Almquist SA. Evaluation of a consecutive group of transsexual individuals referred for vocal intervention in the west of Sweden. Logoped Phoniatr Vocol. 2004;29(1):18-30. doi: 10.1080/14015430310021618.
PubMed 15089001
Study at a glance
From the registry record, last updated by the sponsor on 13 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Speech Therapy in Trans Women.
- ClinicalTrials.gov ID
- NCT04708600
- Acronym / sponsor ID
- B670201941335
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 78 participants (actual)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 1 Sep 2019 (actual)
- Primary completion
- 30 Mar 2023 (actual)
- Study completion
- 30 Mar 2023 (actual)
- First posted
- 14 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.
Detailed description
The main aim of this project is to investigate the short-term and long-term effect of speech therapy for pitch and resonance on vocal characteristics, listeners' perceptions and self-perception in trans women using a randomized sham-controlled trial and a longitudinal cross-over design. The goals of speech therapy are selected based on a systematic review and meta-analysis: pitch and resonance.
The first purpose is to determine and compare the short-term effect of two therapy programs Pitch Elevation Therapy (PET) and Articulation-Resonance Therapy (ART), in trans women on (a) acoustic voice characteristics investigating vocal quality, pitch and resonance, (b) listeners' perceptions using a combination of (binary) gender identification and femininity ratings using a Visual Analogue Scale (VAS) and (c) self-assessment investigating the client's satisfaction of the therapy and psychosocial functioning, using a randomized controlled trial.
Hypotheses:
- Outcome acoustic voice characteristics: Based on studies and our pilot study investigating the immediate effects of resonance and articulation exercises in trans women, a significant increase in all formant frequencies, and an increase in speaking fo is hypothesized after ART. Based on studies, an increase in speaking fo between 10 and 84Hz is hypothesized after PET. The speaking fo and formant frequencies are primary outcome measures. Vocal training and increasing pitch (during the PET) is associated with increasing vocal load and has a possible negative effect on vocal quality. Monitoring vocal quality in the three groups is therefore important. PET includes gliding tones and consequently can have a possible effect on frequency range. Therefore vocal quality and vocal range parameters are included as secondary outcome parameters. PET and ART are designed to feminize the voice without vocal misuse. Therefore, measurements of vocal quality are hypothesized to remain stable after treatment. After PET, an increase in vocal range is hypothesized.
- Outcome listeners perceptions: According to the systematic review and meta-analysis of Leung et al., pitch and resonance are the most salient listener perceptions of speaker gender. Based on the results of our pilot study, and other studies, it is hypothesized that both therapy programs, PET and ART, will result in a more feminine speech rated on a VAS. Based on the results of Gelfer et al. we hypothesize that 50% of the participants will be perceived as female after the PET therapy.
- Outcome self-assessment: Based on a retrospective study, case studies, and another study, significant improvement in psychosocial wellbeing and high levels of satisfaction with the post-treatment voice are hypothesized in both programs.
The second purpose of the study is to determine the short- and long-term effects of the whole therapy program, consisting of the combination of both PET and ART, in transwomen on (a), (b) and (c) immediately after therapy and at 3 months and 1 year using a cross-over design.
Hypotheses:
- Outcome acoustic voice characteristics: Based on a retrospective study and prospective studies on small sample sizes investigating long-term outcome of speech therapy, a small decrease of the speaking fo is hypothesized in the long-term follow-up after one year. The long-term outcome of the formant frequencies remains unclear.
- Outcome listeners perceptions: Based on a pilot study, it is hypothesized that the listeners perceptions immediately after therapy will not differ from the listeners perceptions 3 months and 1 year after therapy.
- Outcome self-assessment: Based on the results of a study and because speech is a crucial element in the psychosocial functioning of a trans women, an increasing improvement in activity and participation after 3 months and 1 year is hypothesized.
Randomized sham- controlled trial group 1 (n=26): pre sham post 1 PET post 2 ART post 3 follow-up 1 follow-up 2 group 2 (n=26): pre sham post 1 ARTpost 2 PET post 3 follow-up 1 follow-up 2
Study design. A randomized sham-controlled trial will be used to determine and compare the short-term effect of PET and ART in trans women. By adding a cross-over design, the effect of a combined treatment (PET and ART) can also be investigated, both on the short- and longer term.
Motivation: A randomized controlled trail is considered the most reliable form of scientific evidence in efficacy studies. The use of a sham therapy will take into account placebo an therapist effects. A cross-over design is used for ethical reasons, so that each subject will receive the whole voice feminization approach (PET and ART) in an acceptable time frame. Follow-up data are included to determine long-term effects of the intervention and track which subjects still need phonosurgery or further behavioral intervention.
Participants. Sample size. To date, no randomized controlled trials investigated the effect of speech therapy in transwomen. Therefore, sample size calculation was based on the study of Dacakis. This pilot study gave a minimal sample size of n = 18 participants per group (SAS, Power and Sample Size). Minimal sample size was calculated for the fundamental frequency with an α level of 0.05, a power of 80%, and a SD of 20 and 15. Taking into account a mean drop-out rate of 30%, minimal sample sizes are increased from 18 to 26 participants per group. It guarantees a large sample size to perform data-analysis with sufficient power. Taking into account the research group's expertise in the field and the accessible recruitment via the gender clinic of UZ Gent, a total of n = 78 participants is a very feasible number.
Inclusion criteria and exclusion criteria for the trans women are described further in the application.
The multidimensional voice assessment will be performed by an SLP (different from the therapist) with more than 5 years of experience of the research group who is blinded to group allocation and study evolution. Assessments will be planned before the treatment (pre), immediately after sham therapy (post 1), immediately after therapy 1 (post 2), immediately after therapy 2 (post 3) and at three months (follow-up 1) and 1 year (follow-up 2) follow-up. All measurements will be performed in a sound treated room (speech lab) at Ghent University Hospital at the department of Rehabilitation Sciences.
Listening experiment.
Listeners: An equal number of male and female naïve, native Dutch speaking laypersons (n=60), aged (and equally spread) between 20 and 49 years old, with a normal hearing will be recruited for the listening experiment. All listeners will be blinded to the purpose of the study and the gender of the speakers of the speech samples. The hearing levels of all listeners will be evaluated by the audiologists of the research team using audiometry.
Table 1: Number of listeners per age group, gender and task.
VAS-scale Binary rating M (n) F (n) M (n) F (n) 20-29y 5 5 5 5 30-39y 5 5 5 5 40-49y 5 5 5 5
Method:
The listeners, who are blinded to the purpose of the study, will be randomly assigned to 2 groups to rate audio samples on masculinity/femininity using a VAS (group 1, n=30) and gender identification (male voice versus female voice) (group 2, n=30).
Speech samples: From the speech samples of continuous speech during reading (using a phonetically balanced text) the middle sentences (+- 15 seconds) will be selected and used in the experiment. For the listening experiment E-prime 3 software is used to randomize and present the samples.
Ratings: The raters will listen once to the samples presented by E-prime 3 software during a PowerPoint presentation using a laptop and over ear headphones in a quiet sound treated room. They can include pauses to maintain concentration levels. Intensity levels will be presented at a comfortable level for the listener (approximately at 70dB at ear level). The listeners will also receive 2 other questions (distracting them from the purpose of the study) regarding the age and vocal quality of the speakers. They will rate the audio samples of all participants (n= 78) at all test moments and of 13 cis-male and 13 cis-female control persons. Inter-rater reliability will be calculated. 15% of the samples will be randomly repeated to calculate intra-rater reliability.
Speech therapy procedures. Trans women will be randomly assigned to one of the 2 groups (PET, ART) using randomization. All groups will receive the same dosage of individual therapy: 10 sessions of one hour during 5 weeks. The interventions will have an equal duration (5 sessions) and will be provided in a different order in both groups: Pitch Elevation Therapy (PET) and Articulation Therapy (ART). All therapies, including the sham therapy, will be provided by the same experienced therapist of the research group, having more than 10y of experience in this field, to control for therapist effects and assure optimal treatment fidelity. Interventions will take place in a sound treated room (speech lab) at Ghent University Hospital (dep. of Rehabilitation Sciences). PET and ART will be described in detail for the publications of this project to ensure replicability. The control group will receive information sessions regarding transgender logopaedic and general health care and, communication aspects, an active intervention for non-verbal communication skills and breathing patterns. Therefore, it is feasible to provide the same duration as the PET and ART interventions.
The same hierarchical structure will be used for both therapy programs and is based on a comprehensive literature searching.
Statistical analysis. Linear mixed model analyses (LMM) (incl. baseline analyses) will be used to determine whether there is a difference in evolution between the therapy groups over time (interaction effect time*group). Within- and between-group differences will be analyzed using post-hoc pairwise comparisons (with Bonferroni correction).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group 1 | Experimental | Behavioral: Pitch Elevation Therapy, Behavioral: Articulation Resonance Therapy, Behavioral: Sham therapySham therapy Intervention 1: PET Intervention 2: ART |
| Group 2 | Experimental | Behavioral: Pitch Elevation Therapy, Behavioral: Articulation Resonance Therapy, Behavioral: Sham therapySham therapy Intervention 1: ART Intervention 2: PET |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- established diagnose and gender identity confirmed by the gender team,
- aged between 18 and 70 years,
- self-reported normal hearing,
- native Dutch speaker,
- under hormonal treatment (confirmed by blood analysis),
Key exclusion criteria (4 listed)
- history of neurological disorders, previous phonosurgery or speech therapy
- pathology of the vocal folds (observed by videolaryngostroboscopic examination of the vocal cords),
- smokers.
- to form a homogeneous study population gender non-binary persons will not be included in this study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pitch Elevation TherapyAlso: PETGoal: mean fundamental frequency of 180Hz (range 140 and 300Hz); Doses and duration: 5 one hour sessions (5h), 5 weeks Content: * auditory discrimination of lower and higher tones * pitch glides * pitch glides using straw phonation and resonance tube phonation * practice of higher pitch voice (target: 180Hz) in isolated vowels - syllables - mono and bisyllabic words -phrases - sentences and texts - conversation (generalization to spontaneous speech) | Behavioural | Group 1, Group 2 |
| Articulation Resonance TherapyAlso: ARTGoal: increase in lipspreading, forward tongue carriage, larynx elevation, forward resonance, precise articulation; 5 sessions Doses and duration: 5 one hour sessions (5h), 5 weeks Content: * auditory and visual discrimination of forward vs backed tongue carriage and lip spreading vs lip rounding) * practice of technique on isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech) * practising larynx elevation through the twang technique, isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech) * forward resonance, focusing on oral forward resonance rather than chest resonance, isolated vowels -syllables -mono and bisyllabic words - phrases - sentences and texts - conversation (generalization to spontaneous speech) * clear, precise articulation and cork exercise | Behavioural | Group 1, Group 2 |
| Sham therapyGoal: active sham treatment, 4 sessions Doses and duration: 4 one hour and 15 minutes sessions (5h), 4 weeks Content: * providing information about vocal function, vocal surgery, vocal hygiene, transgender health care * discussing communication aspects and patterns, possible exercise contexts, communication partners, expectations of voice modification, conversational subjects * active intervention on nonverbal communication (Kinesics, gestures and sign language, facial expression, haptics, proxemics, occulsics, and physical appearance) * practising costo abdominal breathing patterns | Behavioural | Group 1, Group 2 |
Primary outcome
Acoustics: change in speaking fundamental frequency
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Median Speaking fo, fo upper limit (pc95), fo lower limit (pc25)
Acoustics: change in formant frequencies
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Median Formant Frequencies F1-F5 of the vowels /a/, /i/, /u/
Change in listeners perceptions
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
masculinity/femininity ratings (using a VAS) and gender identification
Change in self-assessment
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Trans women voice questionnaire
3 secondary outcomes
Change in Dysphonia Severity Index
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in Acoustic Voice Quality Index
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Change in Voice Range Profile
Time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Dec 2023.
- Background: PubMed 23084812Gelfer MP, Tice RM. Perceptual and acoustic outcomes of voice therapy for male-to-female transgender individuals immediately after therapy and 15 months later. J Voice. 2013 May;27(3):335-47. doi: 10.1016/j.jvoice.2012.07.009. Epub 2012 Oct 22.
- Background: PubMed 11130111Dacakis G. Long-term maintenance of fundamental frequency increases in male-to-female transsexuals. J Voice. 2000 Dec;14(4):549-56. doi: 10.1016/s0892-1997(00)80010-7.
- Background: PubMed 29392290Leung Y, Oates J, Chan SP. Voice, Articulation, and Prosody Contribute to Listener Perceptions of Speaker Gender: A Systematic Review and Meta-Analysis. J Speech Lang Hear Res. 2018 Feb 15;61(2):266-297. doi: 10.1044/2017_JSLHR-S-17-0067.
- Background: PubMed 16301101Gelfer MP, Mikos VA. The relative contributions of speaking fundamental frequency and formant frequencies to gender identification based on isolated vowels. J Voice. 2005 Dec;19(4):544-54. doi: 10.1016/j.jvoice.2004.10.006.
- Background: PubMed 16822646Carew L, Dacakis G, Oates J. The effectiveness of oral resonance therapy on the perception of femininity of voice in male-to-female transsexuals. J Voice. 2007 Sep;21(5):591-603. doi: 10.1016/j.jvoice.2006.05.005. Epub 2006 Jul 5.
- Background: PubMed 15089001Soderpalm E, Larsson A, Almquist SA. Evaluation of a consecutive group of transsexual individuals referred for vocal intervention in the west of Sweden. Logoped Phoniatr Vocol. 2004;29(1):18-30. doi: 10.1080/14015430310021618.
- Individual participant dataSharing planned: No
Related trials for Transgenderism
Enrolling by invitation
Metoidioplasty and Phalloplasty Surgery Decision Making
Gender Dysphoria, Gender Dysphoria, Adult
RecruitingPhase 4
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Transgenderism, Reproductive Issues
RecruitingObservational study
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Transsexualism, Transgenderism
Active, not recruitingObservational study
Cardiometabolic Health in Transgender Males
Transgender, Transgenderism
RecruitingObservational study
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Transgenderism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Evelien D'haeseleer, PhD principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pitch Elevation Therapy and Articulation Resonance Therapy in people with Transgenderism and Gender Dysphoria, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acoustics: change in speaking fundamental frequency (time frame: pre, post 1 (immediately after sham), post 2 (immediately after intervention 1), post 3 (immediately after intervention 2), follow-up 1 (after 3 months), follow-up 2 (after 1 year)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04708600, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2023.